Postprandial glycogen and lipid synthesis in prednisolone-treated rats maintained on high-protein diets with varied carbohydrate levels
2006
Obeid O.A. | Boukarim L.K. | Al Awar R.M. | Hwalla N. | Obeid, O.A., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Boukarim, L.K., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Al Awar, R.M., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Hwalla, N., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Obeid, O.A.; Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon; email: [email protected] | University: American University of Beirut; Faculty: Faculty of Agricultural and Food Sciences; Department: Nutrition and Food Sciences; | Nutrition and Food Sciences | [email protected] | Faculty of Agricultural and Food Sciences | Obeid, OA | Boukarim, LK | Al Awar, RM | Hwalla, N | Obeid, OA (reprint author), Amer Univ Beirut, Fac Agr and Food Sci, Dept Nutr and Food Sci, Beirut, Lebanon. | American University of Beirut
Objective: The present experiment was designed to study the effect of a high-protein, high-carbohydrate diet versus a high-protein, low-carbohydrate diet on in vivo postprandial glycogen and lipid synthesis of rats treated with prednisolone. Methods: Thirty-two 6-wk-old male Sprague-Dawley rats were randomly assigned to one of four equal groups: high-protein, high-carbohydrate; high-protein, high-carbohydrate with prednisolone; high-protein, low-carbohydrate; and high-protein, low-carbohydrate with prednisolone. Rats were sham operated or subcutaneously implanted with prednisolone pellets while being maintained on their respective diets (39percent of energy from protein) for 6 wk. Food intake and body weight were monitored throughout the experiment. At the end of the feeding period, overnight-fasted rats were fed a test meal and injected with 3H2O to measure in vivo rates of glycogen and lipid synthesis. Final plasma glucose, insulin, and triacylglycerol concentrations and hepatic glycogen content were also measured. Results: Results showed that hepatic glycogen content (milligrams per gram of liver) was similar across all four experimental groups. Total hepatic glycogen synthesis and its percentage synthesis via pyruvate (indirect pathway) were higher in rats maintained on the high-protein, high-carbohydrate diet compared with those on the high-protein, low-carbohydrate diet and this was not substantially affected by prednisolone administration. Hepatic and epididymal fat pad lipid syntheses were not altered by diet or prednisolone treatments. Conclusion: Under long-term high-protein conditions, prednisolone administration does not seem to affect hepatic glycogen synthesis, which was increased with the increased carbohydrate content of the diet. © 2006 Elsevier Inc. All rights reserved.
Показать больше [+] Меньше [-]ABE M, 1982, J NUTR, V112, P205; Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034-j.1478-3231.2003.00858.x; AHMED M, 1980, AM J CLIN NUTR, V33, P1917; ANUGWA FOI, 1989, J NUTR, V119, P879; BERDANIER CD, 1989, FASEB J, V3, P2179; Bisschop PH, 2000, J CLIN ENDOCR METAB, V85, P1963, DOI 10.1210-jc.85.5.1963; Bouclaous C, 2003, NUTR RES, V23, P1105, DOI 10.1016-S0271-5317(03)00104-0; BOUCLAOUS C, 2002, THESIS AM U BEIRUT; Cheskin LJ, 1999, SOUTHERN MED J, V92, P898; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006-frne.1993.1010; EMERY PW, 1993, NUTR CANCER, V20, P231; FLATT JP, 1987, ANN NY ACAD SCI, V499, P104, DOI 10.1111-j.1749-6632.1987.tb36202.x; Flatt JP, 1996, INT J OBESITY, V20, pS1; FRIEDMAN.N, 1967, BIOCHEM BIOPH RES CO, V29, P113, DOI 10.1016-0006-291X(67)90550-5; Gannon MC, 2004, DIABETES, V53, P2375, DOI 10.2337-diabetes.53.9.2375; GANNON MC, 2003, AM J CLIN NUTR, V78, P743; GANNON MC, 1987, DIABETES, V36, P52, DOI 10.2337-diabetes.36.1.52; Gannon MC, 2001, J CLIN ENDOCR METAB, V86, P1040, DOI 10.1210-jc.86.3.1040; Goldstein RE, 2002, AM J PHYSIOL-ENDOC M, V283, pE946, DOI 10.1152-ajpendo.00320.2002; KHAN MA, 1992, J AM COLL NUTR, V11, P701; Kusunoki M, 2000, DIABETOLOGIA, V43, P875, DOI 10.1007-s001250051464; la Fleur SE, 2004, ENDOCRINOLOGY, V145, P2174, DOI 10.1210-en.2003-1359; Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007-s001250051521; Mantha L, 2000, AM J PHYSIOL-REG I, V278, pR1424; MCGARRY JD, 1987, ANNU REV NUTR, V7, P51; NUTTALL FQ, 1999, AM DIABETES ASS GUID, P85; Nyachoti CM, 2000, LIVEST PROD SCI, V65, P229, DOI 10.1016-S0301-6226(00)00157-3; Obeid OA, 2000, INT J OBESITY, V24, P508, DOI 10.1038-sj.ijo.0801189; Obeid OA, 2005, NUTRITION, V21, P224, DOI 10.1016-j.nut.2004.03.026; Obeid O. A., 1992, Proceedings of the Nutrition Society, V51, p122A; OKADA M, 1971, J BIOCHEM-TOKYO, V70, P581; Orth D.N., 1992, WILLIAMS TXB ENDOCRI, P489; REBUFFESCRIVE M, 1992, PHYSIOL BEHAV, V52, P583, DOI 10.1016-0031-9384(92)90351-2; REBUFFESCRIVE M, 1988, J CLIN ENDOCR METAB, V67, P1122; ROSSETTI L, 1989, AM J PHYSIOL, V257, pE212; SCHIMASSEK H, 1993, Z NATURFORSCH C, V48, P85; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337-diabetes.40.2.280; Tataranni PA, 1996, AM J PHYSIOL-ENDOC M, V271, pE317; TEMPEL DL, 1994, J NEUROENDOCRINOL, V6, P479, DOI 10.1111-j.1365-2826.1994.tb00611.x; VENKATESAN N, 1987, METABOLISM, V36, P883, DOI 10.1016-0026-0495(87)90098-9; WILLOX JC, 1984, BRIT MED J, V288, P27
Показать больше [+] Меньше [-]Ключевые слова АГРОВОК
Библиографическая информация
Эту запись предоставил American University of Beirut